Albert Arias
Virginia Commonwealth University · Virginia CommonwealthUniversity · Yale University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Albert Arias as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:36 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05886582 · Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use DisorderVirginia Commonwealth University · completed · Substance-Related Disorders · principal investigator
- Ph2NCT05179772 · Olanzapine in OUD PatientsUniversity of Pennsylvania · withdrawn · Opioid Use Disorder · principal investigator
- Ph1/Ph2NCT04502589 · Open Label Pilot Study of Perampanel for the Treatment of Alcohol Use DisorderVirginia Commonwealth University · completed · Alcohol Disorders · principal investigator
- Ph3NCT02900352 · Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of ActionVirginia Commonwealth University · completed · Alcohol Use Disorder · principal investigator
- Ph1/Ph2NCT02120365 · Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol DependenceVirginia Commonwealth University · completed · Alcoholism · principal investigator
- Ph1/Ph2NCT02046551 · Atomoxetine's Effects On Nicotine Response And Stress Response In SmokersYale University · withdrawn · Nicotine Dependence · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use DisordersUG1DA050207 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2020 to 2024 · $504,103 awarded in 2024Same name and institution; not confirmed by an ID
- Zonisamide Treatment of Alcohol Use Disorder: An Evaluation of Efficacy and Mechanism of ActionR01AA024466 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2016 to 2020 · $443,591 awarded in 2020Grant number is on one of their registry trials
- Perampanel Treatment of Alcohol Use DisorderR21AA026681 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2018 to 2019 · $184,359 awarded in 2019Grant number is on one of their registry trials
- Alcohol Dependence: Pharmacotherapy, Pharmacogenetics, and GeneticsK23AA017689 · NIAAA · YALE UNIVERSITY · fiscal years 2010 to 2013 · $169,829 awarded in 2013Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use DisorderU01DA057846 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI James M Bjork · fiscal years 2022Named on NCT05886582
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:36 UTC. The ranking covers the 200 most relevant of 51 PubMed records, and a shared surname and initials can bring in a namesake. All 51 on PubMed
- 678 citationsRCR 30.5
- Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease.J Allergy Clin Immunol · 2013328 citationsRCR 11.8
- Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study.J Allergy Clin Immunol · 2018228 citationsRCR 12.4
- Four-food group elimination diet for adult eosinophilic esophagitis: A prospective multicenter study.J Allergy Clin Immunol · 2014191 citationsRCR 7.7
- Predictive models of pain following root canal treatment: a prospective clinical study.Int Endod J · 2013166 citationsRCR 9.5
- Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.Am J Psychiatry · 2014157 citationsRCR 6.2
- Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.J Allergy Clin Immunol · 2011151 citationsRCR 4.8
- The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.J Exp Med · 2018112 citationsRCR 3.9
- Relationship between postendodontic pain, tooth diagnostic factors, and apical patency.J Endod · 200985 citationsRCR 4.5
- Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial.Alcohol Clin Exp Res · 201685 citationsRCR 4.2